← Back to Search

Behavioural Intervention

Transcutaneous Electrical Nerve Stimulation (TENS) for Cesarean Section Complications

N/A
Waitlist Available
Led By Adrienne Simonds, PT PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 post-operative days
Awards & highlights

Study Summary

This trial will explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. TENS is a non-invasive, drug-free method of pain relief that works by stimulating the nerves with electrical impulses. The study will test whether or not TENS is effective in reducing pain and the need for pain medication in postpartum women. Additionally, the study will evaluate if TENS has any other benefits in postpartum outcomes, such as time to bowel movement, level of sedation, and time to out of bed.

Eligible Conditions
  • Cesarean Section Complications
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 post-operative days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 post-operative days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-operative Pain Ratings
Secondary outcome measures
Post-operative opioid side-effects
Post-operative opioid use
Subjective Pain and Acceptability Questionnaire

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Post-CS TENSExperimental Treatment1 Intervention
The patients in the intervention group will be educated on the proper way to utilize the transcutaneous electrical nerve stimulation (TENS) unit. They will apply the the patches of the TENS unit around the C-section site. Starting 8 hours after C-Section, the TENS unit will be turned on and will remain on until the patient is discharged, to be removed for toilet and showering at the patient's discretion. Once the TENS unit is applied and turned on, the patient will not have to do anything else to maintain the therapy. Routine pharmacologic care will also be available.
Group II: Opioid Addicted Post-CS TENSExperimental Treatment1 Intervention
Subjects will be targeted on the basis of opioid addiction and usage of methadone maintenance. The patients in the intervention group will be educated on the proper way to utilize the transcutaneous electrical nerve stimulation (TENS) unit. They will apply the the patches of the TENS unit around the C-section site). Starting 8 hours after C-Section, the TENS unit will be turned on and will remain on until the patient is discharged, to be removed for toilet and showering at the patient's discretion. Once the TENS unit is applied and turned on, the patient will not have to do anything else to maintain the therapy. Routine pharmacologic care will also be available.
Group III: Post-CS Routine CareActive Control1 Intervention
Routine pharmacologic care will be provided.
Group IV: Opioid Addicted Post-CS Routine CareActive Control1 Intervention
Routine pharmacologic care will be provided.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcutaneous Electrical Nerve Stimulation (TENS)
2023
N/A
~680

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,212 Total Patients Enrolled
Adrienne Simonds, PT PhDPrincipal InvestigatorRutgers School of Health Professions

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~3 spots leftby Apr 2025